Legal Representation
Attorney
Christopher J. Buntel
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 5, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jun 5, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Nov 6, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 6, 2008 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 6, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 4, 2008 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Mar 14, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 4, 2008 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Mar 4, 2008 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 31, 2007 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Aug 31, 2007 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Aug 31, 2007 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jul 25, 2007 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Jul 25, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 19, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 2, 2007 | I | PAPER RECEIVED | Loading... | |
| Jun 28, 2007 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 28, 2007 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 30, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 30, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 30, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 12, 2006 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Aug 11, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research; medical and scientific research services for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; research and development for immunotherapy products for others; technical research and consultation services in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices, development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; medical laboratory services, including intaking, processing and storing blood and cells of the immune system and tumor and infected cells for later scientific and medical research and for activation of immune system cells
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
ACCELERATE
Classification
International Classes
042